Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Bookmark and Share
Published: 5 Jun 2016
Views: 2492
Rating:
Save
Prof James Perry - University of Toronto, Toronto, Canada

Prof Perry talks to ecancertv at ASCO 2016 about a phase III randomised controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma.

Watch the press conference or read the news story for more.

ecancer's filming at ASCO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.